73 related articles for article (PubMed ID: 21626435)
41. δ-Opioid Receptor as a Molecular Target for Increasing Cardiac Resistance to Reperfusion in Drug Development.
Naryzhnaya NV; Mukhomedzyanov AV; Sirotina M; Maslov LN; Kurbatov BK; Gorbunov AS; Kilin M; Kan A; Krylatov AV; Podoksenov YK; Logvinov SV
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509526
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-21 and microRNA-148a affects PTEN, NO and ROS in canine leishmaniasis.
De Freitas JH; Bragato JP; Rebech GT; Costa SF; Dos Santos MO; Soares MF; Eugênio FR; Dos Santos PSP; De Lima VMF
Front Genet; 2023; 14():1106496. PubMed ID: 37124626
[TBL] [Abstract][Full Text] [Related]
43. Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis.
Ren C; Liu K; Zhao X; Guo H; Luo Y; Chang J; Gao X; Lv X; Zhi X; Wu X; Jiang H; Chen Q; Li Y
Front Pharmacol; 2022; 13():853289. PubMed ID: 35754495
[TBL] [Abstract][Full Text] [Related]
44. LncRNA GAS5 suppresses ovarian cancer progression by targeting the miR-96-5p/PTEN axis.
Dong Q; Long X; Cheng J; Wang W; Tian Q; Di W
Ann Transl Med; 2021 Dec; 9(24):1770. PubMed ID: 35071464
[TBL] [Abstract][Full Text] [Related]
45. PMSF Attenuates Morphine Antinociceptive Tolerance and Dependence in Mice: Its Association with the Oxidative Stress Suppression.
Asadi Akbarabadi E; Rajabi Vardanjani H; Molavinia S; Pashmforoosh M; Khodayar MJ
Iran J Pharm Res; 2021; 20(3):300-309. PubMed ID: 34903990
[TBL] [Abstract][Full Text] [Related]
46. New targets of morphine postconditioning protection of the myocardium in ischemia/reperfusion injury: Involvement of HSP90/Akt and C5a/NF-κB.
Tu RH; Wang DX; Zhong GQ; Meng JJ; Wen H; Jie-Feng ; Bi Q; He Y
Open Med (Wars); 2021; 16(1):1552-1563. PubMed ID: 34722891
[TBL] [Abstract][Full Text] [Related]
47. Morphine Prevents Ischemia/Reperfusion-Induced Myocardial Mitochondrial Damage by Activating δ-opioid Receptor/EGFR/ROS Pathway.
Xu J; Bian X; Zhao H; Sun Y; Tian Y; Li X; Tian W
Cardiovasc Drugs Ther; 2022 Oct; 36(5):841-857. PubMed ID: 34279751
[TBL] [Abstract][Full Text] [Related]
48. Opening of mitoKATP improves cardiac function and inhibits apoptosis via the AKT-Foxo1 signaling pathway in diabetic cardiomyopathy.
Duan P; Wang J; Li Y; Wei S; Su F; Zhang S; Duan Y; Wang L; Zhu Q
Int J Mol Med; 2018 Nov; 42(5):2709-2719. PubMed ID: 30132505
[TBL] [Abstract][Full Text] [Related]
49. Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy.
Marengo B; Nitti M; Furfaro AL; Colla R; Ciucis CD; Marinari UM; Pronzato MA; Traverso N; Domenicotti C
Oxid Med Cell Longev; 2016; 2016():6235641. PubMed ID: 27418953
[TBL] [Abstract][Full Text] [Related]
50. Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.
Maslov LN; Khaliulin I; Oeltgen PR; Naryzhnaya NV; Pei JM; Brown SA; Lishmanov YB; Downey JM
Med Res Rev; 2016 Sep; 36(5):871-923. PubMed ID: 27197922
[TBL] [Abstract][Full Text] [Related]
51. Systematic investigation into the role of intermittent high glucose in pancreatic beta-cells.
Shao C; Gu J; Meng X; Zheng H; Wang D
Int J Clin Exp Med; 2015; 8(4):5462-9. PubMed ID: 26131124
[TBL] [Abstract][Full Text] [Related]
52. Certain Diet and Lifestyle May Contribute to Islet β-cells Protection in Type-2 Diabetes via the Modulation of Cellular PI3K/AKT Pathway.
Kitagishi Y; Nakanishi A; Minami A; Asai Y; Yasui M; Iwaizako A; Suzuki M; Ono Y; Ogura Y; Matsuda S
Open Biochem J; 2014; 8():74-82. PubMed ID: 25400709
[TBL] [Abstract][Full Text] [Related]
53. Posttranslational regulation of phosphatase and tensin homolog (PTEN) and its functional impact on cancer behaviors.
Xu W; Yang Z; Zhou SF; Lu N
Drug Des Devel Ther; 2014; 8():1745-51. PubMed ID: 25336918
[TBL] [Abstract][Full Text] [Related]
54. Link between PI3K/AKT/PTEN Pathway and NOX Proteinin Diseases.
Nakanishi A; Wada Y; Kitagishi Y; Matsuda S
Aging Dis; 2014 Jun; 5(3):203-11. PubMed ID: 24900943
[TBL] [Abstract][Full Text] [Related]
55. Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawal.
Martínez-Laorden E; García-Carmona JA; Baroja-Mazo A; Romecín P; Atucha NM; Milanés MV; Laorden ML
Br J Pharmacol; 2014 Feb; 171(3):688-700. PubMed ID: 24490859
[TBL] [Abstract][Full Text] [Related]
56. Crosstalk between G protein-coupled receptors (GPCRs) and tyrosine kinase receptor (TXR) in the heart after morphine withdrawal.
Almela P; García-Carmona JA; Martínez-Laorden E; Milanés MV; Laorden ML
Front Pharmacol; 2013; 4():164. PubMed ID: 24409147
[TBL] [Abstract][Full Text] [Related]
57. Diets involved in PPAR and PI3K/AKT/PTEN pathway may contribute to neuroprotection in a traumatic brain injury.
Kitagishi Y; Matsuda S
Alzheimers Res Ther; 2013; 5(5):42. PubMed ID: 24074163
[TBL] [Abstract][Full Text] [Related]
58. Prolonged morphine administration alters protein expression in the rat myocardium.
Drastichova Z; Skrabalova J; Neckar J; Kolar F; Novotny J
J Biomed Sci; 2011 Nov; 18(1):89. PubMed ID: 22129148
[TBL] [Abstract][Full Text] [Related]
59. The molecular mechanism underlying morphine-induced Akt activation: roles of protein phosphatases and reactive oxygen species.
Xu J; Tian W; Ma X; Guo J; Shi Q; Jin Y; Xi J; Xu Z
Cell Biochem Biophys; 2011 Nov; 61(2):303-11. PubMed ID: 21626435
[TBL] [Abstract][Full Text] [Related]
60. Molecular mechanism underlying Akt activation in zinc-induced cardioprotection.
Lee S; Chanoit G; McIntosh R; Zvara DA; Xu Z
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H569-75. PubMed ID: 19525380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
